Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Semaglutide in Patients With Type 2 Diabetes: Real-world Analysis in the Canadian LMC Diabetes Registry: The SPARE Study

NCT04175665 is registered in ClinicalTrials.gov with LMC Diabetes & Endocrinology Ltd. as lead sponsor.

NCT NCT04175665
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04175665 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Semaglutide in Patients With Type 2 Diabetes: Real-world Analysis in the Canadian LMC Diabetes Registry: The SPARE Study
Lead sponsor
LMC Diabetes & Endocrinology Ltd.
Phase
Observational
Overall status
Completed
Start date
January 6, 2020
Completion date
February 9, 2020
Enrollment
1,133 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

type 2 diabetes